Magnesium Citrate
Active ingredient · 3 therapeutic classes
Sold as citroma
- Drug class
- Osmotically Acting Laxatives
- Availability
- Over-the-counter
- Routes
- Oral, Topical
- Markets covered
- 1
- Products on record
- 10
- FDA reports (12 mo)
- 809
Overview
Plain-language summary, compiled from the cited regulatory records
Magnesium Citrate is an active ingredient classified as an osmotically acting laxative [1]. It is approved for the relief of occasional constipation [1]. This medication generally produces a bowel movement within a timeframe of half an hour to six hours after administration [1].
Magnesium Citrate is available under various brand names, including Citroma [1]. In the past 12 months, there have been 809 adverse event reports associated with this active ingredient [2]. The most frequently reported reactions include off-label use, rash, the drug being ineffective, nausea, and pain [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 10 | April 7, 2026 |
USUnited States· FDA
10 products
Uses
Uses: • For relief of occasional constipation (irregularity). • Generally produces bowel movement in ½ to 6 hours
How to take
Drug interactions
Known interactions involving Magnesium Citrate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 021ebb61-2466-42… · revised March 11, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.